South Africa: In-depth: What We Know About SA's Rampant Gonorrhoea Epidemic
[spotlight] South Africa has one of the highest rates of sexually transmitted infections (STIs) in the world, including for gonorrhoea. It is estimated that every year around two million people in the country get infected with the gonorrhoea bacterium, which is likely to be an underestimate because most women don't show any symptoms, according to a study published in the journal PLOS ONE in 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 4, 2021 Category: African Health Source Type: news

Research establishes antibiotic potential for cannabis molecule
(University of Queensland) The main nonpsychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, which could lead to the first new class of antibiotics for resistant bacteria in 60 years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 19, 2021 Category: Infectious Diseases Source Type: news

A new era is dawning in diagnosing sexually transmitted infections in men
(Estonian Research Council) Researchers and doctors from the University of Tartu and Tartu University Hospital evaluated the use of a novel revolutionary method, flow cytometry, for diagnosing urethritis in Estonian men. The study published in PLOS ONE confirmed the efficiency of the method and showed that most often urethritis was due to chlamydia. Gonorrhoea caused the strongest urethral inflammation. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 3, 2020 Category: International Medicine & Public Health Source Type: news

Number of people with syphilis and gonorrhoea went UP during lockdown in Italy, small study finds
Researchers in Italy compared the number of diagnoses at a clinic in Milan in March and April this year to the same period in 2019. They found a slight increase year-on-year. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2020 Category: Consumer Health News Source Type: news

New research reveals risky sexual behavior and STIs are rising despite COVID-19 pandemic
(Say Communications) New research launched at the 29th EADV Congress, EADV Virtual, has found that despite the COVID-19 (SARS-CoV-2) lockdown restrictions, diagnosis of sexually transmitted infections (STIs), including gonorrhoea, secondary syphilis and mycoplasma genitalium (MG), have increased. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2020 Category: International Medicine & Public Health Source Type: news

Sexually transmitted infections and screening for chlamydia in England, 2019, PHE
Report notes increase in diagnoses of sexually transmitted infections (n=468,342, increase 5%), gonorrhoea (n=70,936; 26%), syphilis (n=7,982; 10%), and Mycoplasma genitalium (5,311; 196%) since 2018, but decreases in first episode genital warts in 15 to 17 year olds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 4, 2020 Category: Consumer Health News Source Type: news

Rise in gonorrhoea cases in England prompts safe sex warning
Annual STI cases are up by 5%, with 70,936 new gonorrhoea diagnoses driving the increase. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 2, 2020 Category: Consumer Health News Source Type: news

Gonorrhoea cases have soared 26% in a year to the highest level since records began
There were 70,936 cases of the sexually transmitted infection in England and Wales last year, the highest number since records began in 1918. It marks a 26 per cent increase from 2018. (Source: the Mail online | Health)
Source: the Mail online | Health - September 2, 2020 Category: Consumer Health News Source Type: news

Lack of antibiotics in low income countries 'worsening  superbugs threat'
Only three new treatments available in 10 or more poorer countries, report findsMany antibiotics are unavailable in poorer countries despite higher infection rates, exacerbating the threat of drug-resistant superbugs, according to a report to bepresented to world leaders and the bosses of top pharmaceutical companies in Davos.The report, released by the Access to Medicine Foundation, an Amsterdam-based non-profit group, also shows that the number of new treatments being developed for common infectious diseases such as pneumonia, tuberculosis and gonorrhoea has fallen.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 21, 2020 Category: Science Authors: Julia Kollewe Tags: Antibiotics Business Davos 2020 Drugs MRSA and superbugs Health Source Type: news

Mobile Clinic team to support people experiencing homelessness
Today, we’re launching a new Mobile Clinic service helping people experiencing homelessness and sleeping rough in the City of London. Volunteer GPs and nurses will offer advice on health conditions, register patients with local GP practices, attend to immediate health needs, provide new socks and gloves and offer screenings for HIV, chlamydia and gonorrhoea. The aim is to work towards sustainable access to healthcare, so that people experiencing homelessness will be able to access mainstream NHS services and rely on them in times of need. We have teamed up with the City of London Corporation, which governs the Squ...
Source: Doctors of the World News - December 3, 2019 Category: International Medicine & Public Health Authors: Martina Villa Tags: Uncategorised Source Type: news

GlaxoSmithKline announces start of phase III trial of gepotidacin in treatment of uncomplicated urinary tract infection (UTI) and urogenital gonorrhoea
Gepotidacin is first in new chemical class of antibiotics called triazaacenaphthylene bacterial topoisomerase inhibitors. Development programme comprises two separate studies, EAGLE-1 (vs. ceftriaxone + azithromycin in gonorrhoea) and EAGLE-2 (vs. nitrofurantoin for UTI). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Government invests in global partnership to treat gonorrhoea
£ 3.5 million investment will enable global access to treatment, including in low-middle-income countries, and fund Global Antibiotic Research and Development Partnership ' s development of oral antibiotic zoliflodacin for treatment of gonorrhoea, now in late stage clinical trials. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Government invests in global partnership to treat gonorrhoea
The government is to invest £3.5m in new treatments for gonorrhoea which are to be made available to low- and middle-income countries. (Source: NHS Networks)
Source: NHS Networks - October 28, 2019 Category: UK Health Source Type: news

GSK starts late-stage study for new-age antibiotic
GlaxoSmithKline has begun a late-stage study testing its experimental antibiotic, gepotidacin, in patients with urinary tract infections and gonorrhoea. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 28, 2019 Category: Pharmaceuticals Source Type: news

GlaxoSmithKline starts late-stage trial for experimental antibiotic
GlaxoSmithKline Plc said on Monday it has begun a late-stage study testing its experimental antibiotic in patients with urinary tract infections and gonorrhoea, a type of sexually transmitted infection. (Source: Reuters: Health)
Source: Reuters: Health - October 28, 2019 Category: Consumer Health News Tags: healthNews Source Type: news